Summary
HCA Healthcare, Inc. reported a strong second quarter for 2025, with consolidated revenues increasing by 6.4% year-over-year to $18.605 billion. This growth was driven by a 3.9% increase in revenue per equivalent admission and a 2.3% rise in equivalent admissions. Net income attributable to HCA Healthcare, Inc. saw a significant jump of 13.1% to $1.653 billion, translating to $6.83 per diluted share, up from $5.53 in the prior year's second quarter. This performance was bolstered by a substantial $2.239 billion increase in cash from operating activities, largely due to favorable working capital changes and a notable decline in income taxes paid thanks to a state tax deferral. The company also continued its share repurchase program, demonstrating a commitment to returning value to shareholders. Despite the positive financial performance, the company faces evolving regulatory landscapes. The recently enacted One Big Beautiful Bill Act (OBBBA) introduces significant changes to Medicaid, potentially impacting patient access and federal health care spending. Additionally, changes to health insurance marketplace rules and the expiration of enhanced premium tax credits could affect payer mix. HCA Healthcare is actively monitoring these developments and implementing resiliency plans. The company's substantial debt load remains a factor, though management believes existing liquidity and access to capital markets are sufficient to meet future needs. Overall, HCA Healthcare delivered robust operational and financial results in the second quarter, while proactively addressing potential regulatory headwinds.
Financial Highlights
45 data points| Revenue | $18.61B |
| Operating Expenses | $16.19B |
| Interest Expense | $568.00M |
| Net Income | $1.65B |
| EPS (Basic) | $6.91 |
| EPS (Diluted) | $6.83 |
| Shares Outstanding (Basic) | 239.17M |
| Shares Outstanding (Diluted) | 241.91M |
Key Highlights
- 1Second quarter 2025 revenues increased 6.4% to $18.605 billion compared to $17.492 billion in the second quarter of 2024.
- 2Net income attributable to HCA Healthcare, Inc. rose 13.1% to $1.653 billion, or $6.83 per diluted share, from $1.461 billion, or $5.53 per diluted share, in the prior year.
- 3Cash flow from operating activities significantly increased by $2.239 billion, reaching $4.210 billion in Q2 2025.
- 4Consolidated revenues were driven by a 3.9% increase in revenue per equivalent admission and a 2.3% increase in equivalent admissions.
- 5The company repurchased 7,031,368 shares of common stock during the second quarter of 2025 under its $10 billion authorization.
- 6The new One Big Beautiful Bill Act (OBBBA) introduces significant healthcare policy changes, particularly to Medicaid, which HCA is monitoring closely.
- 7Salaries and benefits as a percentage of revenue remained stable at 43.7% for the quarter, while supply costs increased by 5.5% per equivalent admission.